Remarkably, our study also revealed ARTS as a biomarker for tumor chemosensitivity, dependent on p53, because overexpression of ARTS enhanced, whereas depletion of ARTS impaired, chemotherapy-induced apoptosis in wild-type p53-harboring cancer cells (Hao et al., 2021a). This evidence concerns the gene TP53 and cancer.